Entry - #614858 - HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14 - OMIM
# 614858

HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
10q26.12 Hypogonadotropic hypogonadism 14 with or without anosmia 614858 AD 3 WDR11 606417
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Nose
- Anosmia (in some patients)
CHEST
Breasts
- Delayed or absent thelarche
GENITOURINARY
- Delayed or absent puberty
Internal Genitalia (Male)
- Small testes (in some patients)
- Cryptorchidism (in some patients)
Internal Genitalia (Female)
- Primary amenorrhea
NEUROLOGIC
Central Nervous System
- Anosmia (in some patients)
ENDOCRINE FEATURES
- Patients have normal pituitary function
- Delayed or absent puberty
- Low testosterone levels in males
- Low estradiol levels in females
- Low or normal serum gonadotropins
MOLECULAR BASIS
- Caused by mutation in the WD repeat-containing protein 11 gene (WDR11, 606417.0001)
Hypogonadotropic hypogonadism with or without anosmia - PS147950 - 27 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p13.1 ?Hypogonadotropic hypogonadism 27 without anosmia AR 3 619755 NHLH2 162361
1q32.1 ?Hypogonadotropic hypogonadism 13 with or without anosmia AR 3 614842 KISS1 603286
2q14.3 {Hypogonadotropic hypogonadism 15 with or without anosmia} AD 3 614880 HS6ST1 604846
3p14.3 Hypogonadotropic hypogonadism 18 with or without anosmia AD, AR, DD 3 615267 IL17RD 606807
3p13 Hypogonadotropic hypogonadism 4 with or without anosmia AD 3 610628 PROK2 607002
4q13.2 Hypogonadotropic hypogonadism 7 without anosmia AR 3 146110 GNRHR 138850
4q24 Hypogonadotropic hypogonadism 11 with or without anosmia AR 3 614840 TACR3 162332
4q27 Hypogonadotropic hypogonadism 25 with anosmia AD 3 618841 NDNF 616506
5q31.3 Hypogonadotropic hypogonadism 17 with or without anosmia AD 3 615266 SPRY4 607984
7q21.11 {Hypogonadotropic hypogonadism 16 with or without anosmia} AD 3 614897 SEMA3A 603961
7q31.32 Hypogonadotropic hypogonadism 22, with or without anosmia AR 3 616030 FEZF1 613301
8p21.3 Hypogonadotropic hypogonadism 20 with or without anosmia AD 3 615270 FGF17 603725
8p21.2 ?Hypogonadotropic hypogonadism 12 with or without anosmia AR 3 614841 GNRH1 152760
8p11.23 Hypogonadotropic hypogonadism 2 with or without anosmia AD 3 147950 FGFR1 136350
8q12.2 Hypogonadotropic hypogonadism 5 with or without anosmia AD 3 612370 CHD7 608892
9q34.3 Hypogonadotropic hypogonadism 9 with or without anosmia AD 3 614838 NSMF 608137
10q24.32 Hypogonadotropic hypogonadism 6 with or without anosmia AD 3 612702 FGF8 600483
10q26.12 Hypogonadotropic hypogonadism 14 with or without anosmia AD 3 614858 WDR11 606417
11p14.1 Hypogonadotropic hypogonadism 24 without anosmia AR 3 229070 FSHB 136530
12q13.3 Hypogonadotropic hypogonadism 10 with or without anosmia AR 3 614839 TAC3 162330
12q21.33 Hypogonadotropic hypogonadism 19 with or without anosmia AD 3 615269 DUSP6 602748
15q21.3 Hypogonadotropic hypogonadism 26 with or without anosmia AD, AR 3 619718 TCF12 600480
19p13.3 Hypogonadotropic hypogonadism 8 with or without anosmia AR 3 614837 KISS1R 604161
19q13.33 Hypogonadotropic hypogonadism 23 with or without anosmia AR 3 228300 LHB 152780
20p12.3 Hypogonadotropic hypogonadism 3 with or without anosmia AD 3 244200 PROKR2 607123
20p12.1 Hypogonadotropic hypogonadism 21 with anosmia AD 3 615271 FLRT3 604808
Xp22.31 Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1) XLR 3 308700 ANOS1 300836

TEXT

A number sign (#) is used with this entry because of evidence that hypogonadotropic hypogonadism-14 with or without anosmia (HH14) can be caused by heterozygous mutation in the WDR11 gene (606417) on chromosome 10q26.


Description

Congenital idiopathic hypogonadotropic hypogonadism (IHH) is a disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. Idiopathic hypogonadotropic hypogonadism can be caused by an isolated defect in gonadotropin-releasing hormone (GNRH; 152760) release, action, or both. Other associated nonreproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss, occur with variable frequency. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism has been called 'Kallmann syndrome (KS),' whereas in the presence of a normal sense of smell, it has been termed 'normosmic idiopathic hypogonadotropic hypogonadism (nIHH)' (summary by Raivio et al., 2007). Because families have been found to segregate both KS and nIHH, the disorder is here referred to as 'hypogonadotropic hypogonadism with or without anosmia (HH).'

For a discussion of genetic heterogeneity of hypogonadotropic hypogonadism with or without anosmia, see 147950.


Cytogenetics

In a 16-year-old boy with Kallmann syndrome, Schinzel et al. (1995) found a tiny chromosome fragment attached to the long arm of chromosome 1, without a visible reciprocal translocation chromosome. Through reverse chromosome painting, they defined an unbalanced der(1),t(1;10)(q44;q26) translocation. This was the third case of Kallmann syndrome with a de novo rearrangement between 2 autosomes. They suggested that the distal long arm of chromosome 1 may contain a candidate gene.


Mapping

Bhagavath et al. (2006) karyotyped 76 HH patients and identified a sporadic male patient with complete hypogonadotropic hypogonadism (no evidence of any puberty) and hyposmia who had a balanced chromosome translocation, reported as 46,XY, t(10;12)(q26.3;q13.1). After excluding copy number variation as the cause of the phenotype, Kim et al. (2010) mapped the translocation breakpoints using fluorescence in situ hybridization (FISH) followed by array painting using a customized oligonucleotide array, resulting in restatement of the karyotype to 46,XY, t(10;12)(q26.12;q13.11). PCR analysis narrowed the breakpoints further and ultimately localized the breakpoint on chromosome 12 between nucleotides 46,038,271 and 46,038,272 and the breakpoint on chromosome 10 between nucleotides 122,053,649 and 122,053,650 (NCBI36). Given previous reports of chromosome 10q26 in association with HH phenotypes (e.g., Schinzel et al., 1995), Kim et al. (2010) hypothesized that 10q was more likely than 12q to harbor the causative gene.


Molecular Genetics

Kim et al. (2010) screened 123 normosmic and hyposmic/anosmic HH patients for mutations in 3 candidate genes on chromosome 10q26, but identified no causative mutations. Sequencing a fourth candidate gene, WDR11 (606417), in 201 normosmic or hyposmic/anosmic HH patients, they identified 5 different heterozygous missense mutations in 6 unrelated probands, including 5 normosmic patients (see, e.g., 606417.0001 and 606417.0002) and 1 anosmic patient (606417.0003). DNA from the parents was unavailable, but the mutations were not found in more than 400 controls.


REFERENCES

  1. Bhagavath, B., Podolsky, R. H., Ozata, M., Bolu, E., Bick, D. P., Kulharya, A., Sherins, R. J., Layman, L. C. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil. Steril. 85: 706-713, 2006. [PubMed: 16500342, related citations] [Full Text]

  2. Kim, H.-G., Ahn, J.-W., Kurth, I., Ullmann, R., Kim, H.-T., Kulharya, A., Ha, K.-S., Itokawa, Y., Meliciani, I., Wenzel, W., Lee, D., Rosenberger, G., and 12 others. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 87: 465-479, 2010. [PubMed: 20887964, images, related citations] [Full Text]

  3. Raivio, T., Falardeau, J., Dwyer, A., Quinton, R., Hayes, F. J., Hughes, V. A., Cole, L. W., Pearce, S. H., Lee, H., Boepple, P., Crowley, W. F., Jr., Pitteloud, N. Reversal of idiopathic hypogonadotropic hypogonadism. New Eng. J. Med. 357: 863-873, 2007. [PubMed: 17761590, related citations] [Full Text]

  4. Schinzel, A., Lorda-Sanchez, I., Binkert, F., Carter, N. P., Bebb, C. E., Ferguson-Smith, M., Eiholzer, U., Zachmann, M., Robinson, W. P. Kallmann syndrome in a boy with a t(1;10) translocation detected by reverse chromosome painting. J. Med. Genet. 32: 957-961, 1995. [PubMed: 8825924, related citations] [Full Text]


Creation Date:
Marla J. F. O'Neill : 10/10/2012
carol : 08/06/2018
carol : 10/11/2012

# 614858

HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14


ORPHA: 432, 478;   DO: 0090087;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
10q26.12 Hypogonadotropic hypogonadism 14 with or without anosmia 614858 Autosomal dominant 3 WDR11 606417

TEXT

A number sign (#) is used with this entry because of evidence that hypogonadotropic hypogonadism-14 with or without anosmia (HH14) can be caused by heterozygous mutation in the WDR11 gene (606417) on chromosome 10q26.


Description

Congenital idiopathic hypogonadotropic hypogonadism (IHH) is a disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. Idiopathic hypogonadotropic hypogonadism can be caused by an isolated defect in gonadotropin-releasing hormone (GNRH; 152760) release, action, or both. Other associated nonreproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss, occur with variable frequency. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism has been called 'Kallmann syndrome (KS),' whereas in the presence of a normal sense of smell, it has been termed 'normosmic idiopathic hypogonadotropic hypogonadism (nIHH)' (summary by Raivio et al., 2007). Because families have been found to segregate both KS and nIHH, the disorder is here referred to as 'hypogonadotropic hypogonadism with or without anosmia (HH).'

For a discussion of genetic heterogeneity of hypogonadotropic hypogonadism with or without anosmia, see 147950.


Cytogenetics

In a 16-year-old boy with Kallmann syndrome, Schinzel et al. (1995) found a tiny chromosome fragment attached to the long arm of chromosome 1, without a visible reciprocal translocation chromosome. Through reverse chromosome painting, they defined an unbalanced der(1),t(1;10)(q44;q26) translocation. This was the third case of Kallmann syndrome with a de novo rearrangement between 2 autosomes. They suggested that the distal long arm of chromosome 1 may contain a candidate gene.


Mapping

Bhagavath et al. (2006) karyotyped 76 HH patients and identified a sporadic male patient with complete hypogonadotropic hypogonadism (no evidence of any puberty) and hyposmia who had a balanced chromosome translocation, reported as 46,XY, t(10;12)(q26.3;q13.1). After excluding copy number variation as the cause of the phenotype, Kim et al. (2010) mapped the translocation breakpoints using fluorescence in situ hybridization (FISH) followed by array painting using a customized oligonucleotide array, resulting in restatement of the karyotype to 46,XY, t(10;12)(q26.12;q13.11). PCR analysis narrowed the breakpoints further and ultimately localized the breakpoint on chromosome 12 between nucleotides 46,038,271 and 46,038,272 and the breakpoint on chromosome 10 between nucleotides 122,053,649 and 122,053,650 (NCBI36). Given previous reports of chromosome 10q26 in association with HH phenotypes (e.g., Schinzel et al., 1995), Kim et al. (2010) hypothesized that 10q was more likely than 12q to harbor the causative gene.


Molecular Genetics

Kim et al. (2010) screened 123 normosmic and hyposmic/anosmic HH patients for mutations in 3 candidate genes on chromosome 10q26, but identified no causative mutations. Sequencing a fourth candidate gene, WDR11 (606417), in 201 normosmic or hyposmic/anosmic HH patients, they identified 5 different heterozygous missense mutations in 6 unrelated probands, including 5 normosmic patients (see, e.g., 606417.0001 and 606417.0002) and 1 anosmic patient (606417.0003). DNA from the parents was unavailable, but the mutations were not found in more than 400 controls.


REFERENCES

  1. Bhagavath, B., Podolsky, R. H., Ozata, M., Bolu, E., Bick, D. P., Kulharya, A., Sherins, R. J., Layman, L. C. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil. Steril. 85: 706-713, 2006. [PubMed: 16500342] [Full Text: https://doi.org/10.1016/j.fertnstert.2005.08.044]

  2. Kim, H.-G., Ahn, J.-W., Kurth, I., Ullmann, R., Kim, H.-T., Kulharya, A., Ha, K.-S., Itokawa, Y., Meliciani, I., Wenzel, W., Lee, D., Rosenberger, G., and 12 others. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 87: 465-479, 2010. [PubMed: 20887964] [Full Text: https://doi.org/10.1016/j.ajhg.2010.08.018]

  3. Raivio, T., Falardeau, J., Dwyer, A., Quinton, R., Hayes, F. J., Hughes, V. A., Cole, L. W., Pearce, S. H., Lee, H., Boepple, P., Crowley, W. F., Jr., Pitteloud, N. Reversal of idiopathic hypogonadotropic hypogonadism. New Eng. J. Med. 357: 863-873, 2007. [PubMed: 17761590] [Full Text: https://doi.org/10.1056/NEJMoa066494]

  4. Schinzel, A., Lorda-Sanchez, I., Binkert, F., Carter, N. P., Bebb, C. E., Ferguson-Smith, M., Eiholzer, U., Zachmann, M., Robinson, W. P. Kallmann syndrome in a boy with a t(1;10) translocation detected by reverse chromosome painting. J. Med. Genet. 32: 957-961, 1995. [PubMed: 8825924] [Full Text: https://doi.org/10.1136/jmg.32.12.957]


Creation Date:
Marla J. F. O'Neill : 10/10/2012

Edit History:
carol : 08/06/2018
carol : 10/11/2012